TherapeuticsMD Inc (TXMD)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -83.14 | -53.85 | -74.669 | -73.705 | -82.004 | -98.219 | 86.175 | -15.367 |
Return on Equity (%) | -94.331 | -59.771 | -116.621 | -330.091 | 319.728 | 158.454 | -383.04 | -31.904 |
Return on Invested Capital (%) | -95.359 | -60.327 | -86.728 | -80.833 | -98.023 | -1394.686 | -12.093 | -60.342 |
Operating Margin (%) | -464.326 | -458.487 | -794.708 | -319.784 | -238.844 | -160.433 | 1.535 | -594.624 |
Net Profit Margin (%) | -464.326 | -458.487 | -823.759 | -354.795 | -282.902 | -198.29 | 160.08 | -789.401 |
Book Value Per Share | 0.334 | 0.321 | 0.175 | -0.078 | -0.346 | -0.22 | 0.15 | 0.123 |
Earnings Per Share | -0.24 | -0.195 | -0.317 | -0.392 | -0.384 | -0.283 | 0.596 | -0.054 |
Cash Per Share | 0.351 | 0.322 | 0.386 | 0.358 | 0.168 | 0.107 | 0.203 | 0.023 |
Working Capital Per Share | 0.332 | 0.32 | 0.348 | 0.346 | 0.145 | -0.219 | 0.045 | 0.026 |
Operating Profit Per Share | 0.04 | 0.036 | 0.032 | 0.096 | 0.102 | 0.119 | 0.368 | 0.007 |
EBIT Per Share | -0.24 | -0.195 | -0.317 | -0.392 | -0.384 | -0.283 | 0.006 | -0.041 |
EBITDA Per Share | -0.24 | -0.195 | -0.317 | -0.392 | -0.384 | -0.283 | 0.006 | -0.041 |
Free Cash Flow Per Share | -0.237 | -0.193 | -0.266 | -0.34 | -0.383 | -0.287 | 0.576 | -0.059 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 196,69M | 216,43M | 240,46M | 271,18M | 299,77M | 429,89M | N/A | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | -543.269 | N/A | N/A | N/A | -258.466 | N/A | N/A |
Net Profit Margin (%) | N/A | -866.106 | N/A | N/A | N/A | -234.505 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 48,52M |
Ratio cours/bénéfice | -4,72 |
Ratio prix/ventes | 37,25 |
Ratio prix/liquidités | 11,21 |
Ratio prix/valeur comptable | 1,66 |
Rendement de dividende | - |
Actions en circulation | 43,72M |
Volume moyen (1 semaine) | 3,19M |
Volume moyen (1 mois) | 938,09k |
Variation sur 52 semaines | -52,36% |
Plus haut sur 52 semaines | 2,75 |
Plus bas sur 52 semaines | 0,70 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales